Alfred Scheidegger
Director/Board Member at DOTTIKON ES HOLDING AG
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Markus Blocher | M | 53 |
Dottikon Es Management AG
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | 21 years |
Marlene Born | F | 49 |
Dottikon Es Management AG
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | 19 years |
Urs Brändli | M | 64 |
Dottikon Es Management AG
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | 34 years |
Emanuel Tschannen | M | 49 |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | 8 years |
Amy Burroughs | F | 54 |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | 5 years |
Karin Krause | F | 56 |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland.
Dottikon Es Management AG
| 9 years |
Thomas Früh | M | 67 |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland.
Dottikon Es Management AG
| - |
Martin Mattingly | M | 66 | 10 years | |
Thilo Schroeder | M | 42 |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 12 years |
Stephan Kirschbaum | M | 57 |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | 15 years |
William LaRue | M | 73 | 10 years | |
Max Bachmann | M | 70 |
Dottikon Es Management AG
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | - |
Rudolf Gygax | M | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals.
The Genetics Co., Inc.
The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates. | 8 years |
Peter Ryser | M | 72 |
Swiss Federal Institute of Technology
| 26 years |
Niresh Berinpanathan | M | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 5 years |
Richard Ebright | M | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 4 years |
Kevin Huang | M | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 5 years |
Lukas Rindlisbacher | M | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 5 years |
Gabor Gyulveszi | M | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 4 years |
Thomas Lips | M | 75 |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 10 years |
Melissa McCracken | M | 37 |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 5 years |
Carmen Diez | F | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 6 years |
Ari Helenius | M | - |
Swiss Federal Institute of Technology
| 27 years |
Marco Weibel | M | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 9 years |
Jakob Loven | M | 46 |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 7 years |
Hans-Beat Gürtler | M | 78 |
The Genetics Co., Inc.
The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates. | - |
Rocco Sgobbo | M | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 8 years |
Peter Rickli | M | - |
The Genetics Co., Inc.
The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates. | - |
Bernhard Urwyler | M | 66 | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Laura Shawver | M | 66 |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | 8 years |
Pascal Jean-Noël Noth | M | - |
Swiss Federal Institute of Technology
| 4 years |
Paul Walker | M | 49 | - | |
Oliver Wyrsch | M | 47 |
Swiss Federal Institute of Technology
| 5 years |
Maurus Maissen | M | 50 |
Swiss Federal Institute of Technology
| 6 years |
Peter Kappeler | M | 55 |
Swiss Federal Institute of Technology
| 6 years |
Patricia L. Bitar | F | 65 | 4 years | |
Damir Filipovic | M | 54 |
Swiss Federal Institute of Technology
| 8 years |
Roland Reber | M | 54 |
Swiss Federal Institute of Technology
| 4 years |
Cyril Vancura | M | - |
Swiss Federal Institute of Technology
| 7 years |
Leena Kaisa Elviira Eskola | M | 62 |
Swiss Federal Institute of Technology
| 3 years |
Christoph Heinzen | M | - |
Swiss Federal Institute of Technology
| 4 years |
Myoung-Ok Kwon | M | 53 |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 6 years |
André Schwaninger | M | - |
Swiss Federal Institute of Technology
| 5 years |
Daniel Ammann | M | 54 |
Swiss Federal Institute of Technology
| 2 years |
Mauro Pedrazzini | M | 59 |
Swiss Federal Institute of Technology
| 3 years |
Adrian Eberle | M | 52 |
Swiss Federal Institute of Technology
| 4 years |
Martin à Porta | M | 54 |
Swiss Federal Institute of Technology
| 1 years |
Jason Wright | M | - |
Swiss Federal Institute of Technology
| 3 years |
Kristina Beeler-Kakalacheva | F | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 3 years |
Christian Bruch | M | 54 |
Swiss Federal Institute of Technology
| 4 years |
Pierre C. Fazan | M | - |
Swiss Federal Institute of Technology
| - |
Andrea Orzati | M | 51 |
Swiss Federal Institute of Technology
| 4 years |
Marc A. Pointet | M | 50 |
Swiss Federal Institute of Technology
| 4 years |
Suzanne M. Obenshain | F | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 1 years |
Patrick Weiss | M | 54 |
Swiss Federal Institute of Technology
| 1 years |
Raymond Schnidrig | M | 55 |
Swiss Federal Institute of Technology
| 5 years |
Wolfram Grüning | M | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 2 years |
André Frei | M | 48 |
Swiss Federal Institute of Technology
| 5 years |
Sinikka Demaré | F | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 3 years |
Kim Nguyen | M | - |
Swiss Federal Institute of Technology
| 4 years |
Olivier Verscheure | M | 52 |
Swiss Federal Institute of Technology
| 3 years |
Niklaus Mannhart | M | 57 |
Swiss Federal Institute of Technology
| 6 years |
Christian Dominique Coppey | M | 59 |
Swiss Federal Institute of Technology
| 3 years |
Elena Cortona | M | 54 |
Swiss Federal Institute of Technology
| 3 years |
Sita Monica Mazumder | M | 54 |
Swiss Federal Institute of Technology
| 5 years |
Philipp Rickenbacher | M | 53 |
Swiss Federal Institute of Technology
| 5 years |
Mat Peyron | M | - |
Swiss Federal Institute of Technology
| 24 years |
Pierre Caloz | M | 52 |
Swiss Federal Institute of Technology
| 1 years |
Wolfgang Renner | M | 57 |
Swiss Federal Institute of Technology
| 3 years |
Frank Lehmann | M | - |
Swiss Federal Institute of Technology
| 4 years |
Serguei Okhonin | M | - |
Swiss Federal Institute of Technology
| 3 years |
Felix Graf | M | 57 |
Swiss Federal Institute of Technology
| 3 years |
Andreas Thiel | M | 56 |
Swiss Federal Institute of Technology
| 3 years |
Matthias Rosenthal | M | - |
Swiss Federal Institute of Technology
| 3 years |
Jean-Pierre Wyss | M | 55 |
Swiss Federal Institute of Technology
| 2 years |
Dirk Muench | M | - |
Swiss Federal Institute of Technology
| 6 years |
Michael Tobias Stumpp | M | 52 |
Swiss Federal Institute of Technology
| 4 years |
Thomas Schluep | M | - |
Swiss Federal Institute of Technology
| 3 years |
Peter Mozerov | M | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 3 years |
Katrin Tissonnier | F | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 8 years |
Hans-Christian Perle | M | - |
Swiss Federal Institute of Technology
| 6 years |
Roland Ruckstuhl | M | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 7 years |
Mátyás Végh | M | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 2 years |
Alexander Ernst | M | 57 |
Swiss Federal Institute of Technology
| 3 years |
Renato S. Pellegrini | M | - |
Swiss Federal Institute of Technology
| 4 years |
Wei Cai | M | 65 |
Swiss Federal Institute of Technology
| - |
Valentin Piëch | M | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 3 years |
Matthias Stuber | M | - |
Swiss Federal Institute of Technology
| 3 years |
Camille Therre | F | - |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | 4 years |
Christoph Niederberger | M | 47 |
Swiss Federal Institute of Technology
| 4 years |
Daniele Inaudi | M | - |
Swiss Federal Institute of Technology
| - |
Bernhard Vögeli | M | - |
Swiss Federal Institute of Technology
| 9 years |
Aron Braun | M | - |
Swiss Federal Institute of Technology
| 6 years |
Lewis J. Shuster | M | 68 |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | - |
Oscar Buset | M | - |
Swiss Federal Institute of Technology
| 3 years |
Barbara Frei-Spreiter | M | 54 |
Swiss Federal Institute of Technology
| 3 years |
Johnny Vaccaro | M | 55 |
Swiss Federal Institute of Technology
| 4 years |
Rochus Kobler | M | 55 |
Swiss Federal Institute of Technology
| 4 years |
Espen Edwin Wiik | M | 52 |
Swiss Federal Institute of Technology
| 1 years |
Heinz Boller | M | 82 | 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
Germany | 57 | 57.00% |
Switzerland | 36 | 36.00% |
United States | 7 | 7.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alfred Scheidegger
- Personal Network